Until we better understand their action on the brain, its far too soon to call GLP-1 and GIP inhibitors miracle drugs for more conditions beyond type 2 diabetes and obesity. A common and debilitating condition Loss of control eating is an extremely common problem, affecting millions of patients with obesity as well as various eating disorders
Gut microbiota and its metabolites in depression: from pathogenesis to treatment
How does the metabolic process of exenatide in the kidneys and liver differ from the pathways utilized by liraglutide and semaglutide, and what implications might these differences have for patients with renal impairment
It is expected that thousands more plaintiffs will join this lawsuit as they experience the negative and severe side effects of Rybelsus
nigra activity against renal diseases Recent preclinical investigations support the nephroprotective potential of Brassica nigra sprout hydroalcoholic extracts (BNSE) in rodent models of renal injury
coli 20SC1DM33, in which bacterial loads in both the liver and spleen were reduced by three orders of magnitude after treatment with meropenem + GSSG (Fig